Skip to main content
. 2021 Aug 27;9(9):956. doi: 10.3390/vaccines9090956

Table 2.

Summary of published cases of rhabdomyolysis associated with COVID-19 vaccinations.

Case Report Vaccine Age, Sex Time to Symptom Onset Peak CK Level Acute Kidney Failure Outcome Note
Tan et al., 2021 ChAdOx1 nCoV-19
(AstraZeneca)
27, m 5 h 250,000 U/L no recovered known CPT2 deficiency
Mack et al., 2021 mRNA-1273
(Moderna)
80, m 2 days 6546 U/L no recovered -
Nassar et al., 2021 BNT161b2 mRNA (Pfizer/BioNTech) 21, m 1 day >22,000 U/L no recovered -